Trueblue (TBI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Q1 2026 revenue grew 8% year-over-year to $399 million, with 7% organic growth, driven by skilled verticals such as energy and commercial driving, while net loss widened to $20 million due to a $4 million non-cash goodwill impairment charge.
Gross margin declined to 19.8% from 23.3%, mainly due to lower workers' compensation reserve benefits and a revenue mix shift toward lower-margin energy work.
SG&A expenses decreased by 8% to $87 million, reflecting disciplined cost management and improved operational efficiency.
Adjusted EBITDA improved to -$3 million from -$4 million in the prior year.
Enhanced sales capacity, strategic partnerships, and digital innovation, including AI integration, supported new business wins and operational scalability.
Financial highlights
Total revenue reached $399 million (up 8% year-over-year; 7% organic growth), with $4 million contributed by the HSP acquisition.
Gross margin was 19.8%, down from 23.3% year-over-year.
Net loss was $19.8 million, including a $4 million non-cash goodwill impairment; adjusted net loss was $12 million.
Cash at period end: $24 million; debt: $74 million; total liquidity: $60 million.
SG&A as a percentage of revenue improved to 21.9% from 25.6% year-over-year.
Outlook and guidance
Q2 2026 revenue expected between $405 million and $430 million, up 2% to 8% year-over-year, with gross margin projected at 21.1% to 21.5%.
SG&A expected at $85 million to $89 million, down 5% to 1% year-over-year.
Highest volumes anticipated in the second half of 2026 due to seasonality, with further margin improvement projected.
Management expects continued expansion in skilled and healthcare verticals, but notes ongoing cost pressures and market uncertainty in permanent hiring.
FY 2026 CapEx planned at $11 million to $15 million; minimal income tax expense expected.
Latest events from Trueblue
- All proposals were approved by shareholders, with no questions raised during the meeting.TBI
AGM 202614 May 2026 - Proxy covers director elections, executive pay, incentive plan, auditor, and ESG priorities.TBI
Proxy filing14 Apr 2026 - Board refreshment and profitability initiatives advance as proxy contest with EHS continues.TBI
Proxy Filing3 Mar 2026 - Revenue up 8% to $418M, but net loss widened on impairment; margin pressure persists.TBI
Q4 202518 Feb 2026 - Q2 revenue down 17% to $396M, net loss $105M, with cost cuts and digital focus amid uncertainty.TBI
Q2 20242 Feb 2026 - Digital innovation and market expansion drive growth and margin gains in a fragmented staffing sector.TBI
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 revenue dropped 19.2% with a $59.1M goodwill impairment and strong cost controls.TBI
Q3 202416 Jan 2026 - Board refreshment and strategic initiatives position the company for long-term growth.TBI
Proxy Filing9 Jan 2026 - Board refreshment and strategic focus highlighted as proxy process begins for 2026.TBI
Proxy Filing9 Jan 2026